News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hutchison MediPharma Options Program to Ortho-McNeil-Janssen Pharmaceuticals, Inc.


2/5/2009 2:55:36 PM

Hutchison MediPharma Limited and Ortho-McNeil-Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson have formed a collaboration, taking advantage of MediPharma’s work on a novel inflammation/immunology target. MediPharma will continue its discovery and development activities through clinical proof-of-concept, unless OMJPI exercises an option to take over the development. If that happens, OMJPI will have exclusive rights to develop and commercialize the compounds. More details...

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES